4.1 Article

Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults

期刊

ABDOMINAL IMAGING
卷 40, 期 8, 页码 3070-3077

出版社

SPRINGER
DOI: 10.1007/s00261-015-0542-5

关键词

Proton density fat fraction; PDFF; Hepatic steatosis; Obesity; Intra-examination repeatability; Inter-examination repeatability; Magnitude-based MRI; Complex-based MRI; Magnetic resonance spectroscopy; Quantitative imaging biomarkers

资金

  1. National Institutes of Health [NIDDK R01 DK075128, NIDDK R01 DK088925, NCMHD EXPORT P60 MD00220, NIH T32 EB005970, UL1TR000100]

向作者/读者索取更多资源

Determine intra- and inter-examination repeatability of magnitude-based magnetic resonance imaging (MRI-M), complex-based magnetic resonance imaging (MRI-C), and magnetic resonance spectroscopy (MRS) at 3T for estimating hepatic proton density fat fraction (PDFF), and using MRS as a reference, confirm MRI-M and MRI-C accuracy. Twenty-nine overweight and obese pediatric (n = 20) and adult (n = 9) subjects (23 male, 6 female) underwent three same-day 3T MR examinations. In each examination MRI-M, MRI-C, and single-voxel MRS were acquired three times. For each MRI acquisition, hepatic PDFF was estimated at the MRS voxel location. Intra- and inter-examination repeatability were assessed by computing standard deviations (SDs) and intra-class correlation coefficients (ICCs). Aggregate SD was computed for each method as the square root of the average of first repeat variances. MRI-M and MRI-C PDFF estimation accuracy was assessed using linear regression with MRS as a reference. For MRI-M, MRI-C, and MRS acquisitions, respectively, mean intra-examination SDs were 0.25%, 0.42%, and 0.49%; mean intra-examination ICCs were 0.999, 0.997, and 0.995; mean inter-examination SDs were 0.42%, 0.45%, and 0.46%; and inter-examination ICCs were 0.995, 0.992, and 0.990. Aggregate SD for each method was < 0.9%. Using MRS as a reference, regression slope, intercept, average bias, and R (2), respectively, for MRI-M were 0.99%, 1.73%, 1.61%, and 0.986, and for MRI-C were 0.96%, 0.43%, 0.40%, and 0.991. MRI-M, MRI-C, and MRS showed high intra- and inter-examination hepatic PDFF estimation repeatability in overweight and obese subjects. Longitudinal hepatic PDFF change > 1.8% (twice the maximum aggregate SD) may represent real change rather than measurement imprecision. Further research is needed to assess whether examinations performed on different days or with different MR technologists affect repeatability of MRS voxel placement and MRS-based PDFF measurements.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease

Kimberly P. Newton, Laura A. Wilson, Nancy A. Crimmins, Mark H. Fishbein, Jean P. Molleston, Stavra A. Xanthakos, Cynthia Behling, Jeffrey B. Schwimmer

Summary: The study aimed to determine the incidence of type 2 diabetes (T2D) in children with nonalcoholic fatty liver disease (NAFLD) and identify associated risk factors. The results showed a high incidence rate of T2D in children with NAFLD, and being female, having a higher BMI z-score, and more severe liver histology were independent risk factors for T2D development.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis

Rohit Loomba, Daniel Q. Huang, Arun J. Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J. Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S. Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gomez, Manal F. Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M. Younossi, Robert P. Myers

Summary: In patients with non-alcoholic steatohepatitis (NASH), liver stiffness (LS) measured by vibration-controlled transient elastography (VCTE) can predict the progression of cirrhosis and the risk of liver decompensation.
Article Gastroenterology & Hepatology

Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH

Darren Jun Hao Tan, Veronica Wendy Setiawan, Cheng Han Ng, Wen Hui Lim, Mark D. Muthiah, Eunice X. Tan, Yock Young Dan, Lewis R. Roberts, Rohit Loomba, Daniel Q. Huang

Summary: This study estimated sex differences in the burden of liver cancer globally and found that males have a higher burden. However, the incidence and death rates of NASH-associated liver cancer in females approach that of males.

HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors

Daniel Q. Huang, Philippe Mathurin, Helena Cortez-Pinto, Rohit Loomba

Summary: Global alcohol consumption has increased, leading to a rise in the incidence of alcohol-associated cirrhosis and hepatocellular carcinoma. Heavy alcohol consumption is a major cause of morbidity and mortality. Measures are needed to reduce the burden of alcohol-related liver diseases.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin

Rebecca W. Zeng, Jie Ning Yong, Darren J. H. Tan, Clarissa E. Fu, Wen Hui Lim, Jieling Xiao, Kai En Chan, Caitlyn Tan, Xin Lei Goh, Douglas Chee, Nicholas Syn, Eunice X. Tan, Mark D. Muthiah, Cheng Han Ng, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Mindie H. Nguyen, Rohit Loomba, Daniel Q. Huang

Summary: An updated meta-analysis suggests that the use of statins and aspirin is associated with a reduced risk of hepatocellular carcinoma, while the use of metformin is not. These findings have implications for future clinical trial design.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

Original Article: prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma

Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B. B. McCormick, Susan P. P. Fisher-Hoch, Rohit Loomba

Summary: This study assessed the risk of significant hepatic fibrosis in first-degree relatives of Mexican Americans with hepatocellular carcinoma (HCC). The results showed a high prevalence of significant fibrosis and definite hepatic steatosis in first-degree relatives, particularly those with diabetes. Screening for liver disease could benefit this population.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, Heather Hofflich, Karen Cadman, Scarlett Lopez, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Cynthia Behling, Claude B. Sirlin, Rohit Loomba

Summary: This study evaluated the prevalence of advanced fibrosis and cirrhosis in patients with T2DM, and found that the prevalence of fibrosis was 14% and cirrhosis was 6%. These results highlight the high risk of advanced fibrosis/cirrhosis in T2DM patients aged >-50 years.

JOURNAL OF HEPATOLOGY (2023)

Correction Radiology, Nuclear Medicine & Medical Imaging

Point-of-care magnetic resonance technology to measure liver fat: Phantom and first-in-human pilot study (88, pg 1794, 2022)

Mark Barahman, Eduardo Grunvald, Pablo J. Prado, Alejandro Bussandri, Walter C. Henderson, Tanya Wolfson, Kathryn J. Fowler, Claude B. Sirlin

MAGNETIC RESONANCE IN MEDICINE (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis

Sunyoung Lee, Yeun-Yoon Kim, Jaeseung Shin, Won Jeong Son, Yun Ho Roh, Jin-Young Choi, Claude B. Sirlin, Victoria Chernyak

Summary: The study aimed to estimate the percentages of hepatocellular carcinoma (HCC) and overall malignancy for each LI-RADS category using CT and MRI. The pooled percentages of HCC and overall malignancy did not differ between CT, MRI with extracellular contrast agents, and MRI with gadoxetate for any LI-RADS category.

RADIOLOGY (2023)

Article Oncology

Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204

Jessica P. Hwang, Kathryn B. Arnold, Joseph M. Unger, Rashmi Chugh, Monica A. Tincopa, Rohit Loomba, Dawn Hershman, Scott D. Ramsey

Summary: This study investigated the adherence to practice guidelines in patients with HBV, HCV, or HIV receiving anticancer treatment. It was found that many patients did not receive guideline-recommended antiviral treatment, indicating a need for further education to improve adherence to guidelines.

SUPPORTIVE CARE IN CANCER (2023)

Article Computer Science, Interdisciplinary Applications

Monte Carlo modeling of hepatic steatosis based on stereology and spatial distribution of fat droplets

Jinyang Wang, Xiaoben Li, Mengyuan Ma, Changqing Wang, Claude B. Sirlin, Scott B. Reeder, Diego Hernando

Summary: This study aimed to model hepatic steatosis in adult humans with non-alcoholic fatty liver disease based on the stereology and spatial distribution of fat droplets. Histological analysis of liver biopsy specimens was performed, and the morphological features of fat droplets were characterized using the gamma distribution function in 2D and 3D spaces. Correlation analysis showed a strong relationship between the morphological features and fat fraction. Monte Carlo modeling was used to simulate the distribution of fat droplets in tissue. This study provides insights into the MRI signal behavior in the presence of liver steatosis.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

LI-RADS: Looking Back, Looking Forward

Victoria Chernyak, Kathryn J. Fowler, Richard K. G. Do, Aya Kamaya, Yuko Kono, An Tang, Donald G. Mitchell, Jeffrey Weinreb, Cynthia S. Santillan, Claude B. Sirlin

Summary: Since its release in 2011, LI-RADS has evolved from a single algorithm for HCC diagnosis to a multialgorithm system covering all major liver imaging modalities. It has achieved global adoption in clinical care and research and unified HCC diagnostic systems in the US. However, there are still gaps in knowledge, such as challenges in surveillance, diagnostic population definition, and reporting. Future directions will focus on addressing these challenges and incorporating advanced technologies to create a probability-based system for liver cancer diagnosis and prognostication.

RADIOLOGY (2023)

Letter Radiology, Nuclear Medicine & Medical Imaging

Locoregional Therapy of Hepatocellular Carcinoma: Reporting Recommendations from the Liver Imaging Reporting and Data System and Society of Interventional Radiology Reporting Committees to Improve Assessment of Response

Alexandra Roudenko, Zachary Berman, Joshua Cornman-Homonoff, Neil Halin, Mark Kleedehn, Kathryn J. Fowler, Mishal Mendiratta-Lalla, Victoria Chernyak, Claude B. Sirlin, Guilherme Moura Cunha

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2023)

Review Gastroenterology & Hepatology

Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology

Daniel Q. Q. Huang, Amit G. Singal, Fasiha Kanwal, Pietro Lampertico, Maria Buti, Claude B. Sirlin, Mindie H. Nguyen, Rohit Loomba

Summary: In this review, the authors discuss the current status of hepatocellular carcinoma (HCC) surveillance and the challenges that remain. They highlight the changing causes of liver disease and the need for strategies to improve the utilization and quality of surveillance. The underutilization of surveillance is attributed to limited disease awareness, knowledge gaps, and difficulty in identifying high-risk individuals. Non-alcoholic fatty liver disease and alcohol-associated liver disease are emerging as significant causes of HCC-related death, posing unique barriers to surveillance. The sensitivity of current surveillance approaches is limited, especially for patients with cirrhosis or obesity.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging Findings in Cirrhotic Liver: Pearls and Pitfalls for Diagnosis of Focal Benign and Malignant Lesions

Xiaoyang Liu, Stephanie B. M. Tan, Muhammad O. Awiwi, Hyun-Jung Jang, Victoria Chernyak, Kathryn J. Fowler, Akram M. Shaaban, Claude B. Sirlin, Alessandro Furlan, Robert M. Marks, Khaled M. Elsayes

Summary: Cirrhosis, the end stage of chronic liver disease, is a major risk factor for hepatocellular carcinoma (HCC). Benign and malignant lesions in cirrhosis can have both typical and atypical imaging features, which can be accurately diagnosed through various imaging modalities.

RADIOGRAPHICS (2023)

暂无数据